首页 | 本学科首页   官方微博 | 高级检索  
检索        

罗格列酮对RAW 264.7细胞源性泡沫细胞炎症反应及SOCS1和SOCS3表达的影响
引用本文:李飞,袁勇,董吁钢,董剑廷,冯力,邓志华.罗格列酮对RAW 264.7细胞源性泡沫细胞炎症反应及SOCS1和SOCS3表达的影响[J].中国病理生理杂志,2013,29(2):261-265.
作者姓名:李飞  袁勇  董吁钢  董剑廷  冯力  邓志华
作者单位:1中山市人民医院心血管内科, 广东 中山 528400; 2中山大学附属第一医院心血管内科,广东 广州 510080
基金项目:中山市科技计划项目(No.20091A08)
摘    要: 目的:观察过氧化物酶体增殖物激活受体γ(PPARγ)配体罗格列酮是否能够调节泡沫细胞促炎/抗炎反应以及细胞因子信号抑制物1(SOCS1)和细胞因子信号抑制物3(SOCS3)的表达。方法:采用ELISA法测定泡沫细胞培养液中肿瘤坏死因子α (TNF-α)、白细胞介素(IL)-6和IL-10的水平,并计算TNF-α/IL-10和IL-6/IL-10的比值。采用RT-PCR及Western blotting技术分别观察RAW 264.7细胞源性泡沫细胞SOCS1和SOCS3 mRNA及蛋白的表达。结果:RAW 264.7细胞源性泡沫细胞组细胞培养液中TNF-α、IL-6和IL-10的水平以及TNF-α/IL-10和IL-6/IL-10的比值均明显高于对照组(control)组。而罗格列酮加入泡沫细胞培养液24 h后,TNF-α、IL-6和IL-10的浓度以及TNF-α/IL-10和IL-6/IL-10的比值均明显低于泡沫细胞组。Control组和泡沫细胞组只有少量SOCS1和SOCS3 mRNA及蛋白的表达,罗格列酮作用于泡沫细胞后SOCS1和SOCS3 mRNA及蛋白的表达均明显高于control组和氧化低密度脂蛋白(ox-LDL)组。结论: 罗格列酮上调泡沫细胞SOCS1和SOCS3的表达,抑制泡沫细胞分泌TNF-α、IL-6和IL-10,调节了泡沫细胞促炎/抗炎反应。

关 键 词:动脉硬化  炎症  细胞因子类  细胞因子信号抑制物  泡沫细胞  
收稿时间:2012-09-05

Effects of rosiglitazone on expression of SOCS1/SOCS3 and inflammatory reaction in RAW 264.7 cell-derived foam cells
LI Fei,YUAN Yong,DONG Yu-gang,DONG Jian-ting,FENG Li,DENG Zhi-hua.Effects of rosiglitazone on expression of SOCS1/SOCS3 and inflammatory reaction in RAW 264.7 cell-derived foam cells[J].Chinese Journal of Pathophysiology,2013,29(2):261-265.
Authors:LI Fei  YUAN Yong  DONG Yu-gang  DONG Jian-ting  FENG Li  DENG Zhi-hua
Institution:1Department of Cardiology, Municipal Hospital of Zhongshan City, Zhongshan 528400, China; 2Department of Cardiology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Abstract:AIM: To investigate whether perioxisome proliferator-activated receptor γ (PPARγ) ligand rosiglitazone regulates suppressor of cytokine signaling 1 (SOCS1) and SOCS3 expression as well as pro-inflammatory/anti-inflammatory responses in RAW 264.7 cell-derived foam cells. METHODS: The concentrations of TNF-α, IL-6 and IL-10 in the cultured supernatant of RAW 264.7 cell-derived foam cells were detected by ELISA, and the ratios of TNF-α/IL-10 and IL-6/IL-10 were calculated. RT-PCR and Western blotting were used to analyze the effects of rosiglitazone on the expression of SOCS1 and SOCS3 at mRNA and protein levels. RESULTS: The concentrations of TNF-α, IL-6 and IL-10, and ratios of TNF-α/IL-10 and IL-6/IL-10 in foam cell group were obviously higher than those in control group, but the concentrations of the above factors in oxidized low-density lipoprotein (ox-LDL) +rosiglitazone group were apparently lower than those in foam cell group. The expression of SOCS1 and SOCS3 at mRNA and protein levels in oxLDL+rosiglitazone group was apparently higher than that in control and foam cell group. CONCLUSION: PPARγ ligand rosiglitazone up-regulates the expression of SOCS1 and SOCS3 at mRNA and protein levels and regulates the balance of pro-inflammatory/anti-inflammatory responses in RAW 264.7 cell-derived foam cells.
Keywords:Atherosclerosis  Inflammation  Cytokines  Suppressors of cytokine signaling  Foam cells
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号